Development of an improved assay system for activated platelet counts and evaluation by aspirin monitoring

Translational Research

Volumn 155, Issue 2, 2010, Pages 89-96

  Okano, Kozue ^a   Naitou, Ayako ^b   Yamamoto, Misa ^a   Araki, Minako ^c   Mimura, Yuka ^a   Ichihara, Kiyoshi ^a   Yamada, Osamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^c Onoda Red Cross Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; EDETIC ACID; FORMALDEHYDE; GLYOXAL;

ADULT; ARTICLE; DRUG MONITORING; DRUG POTENCY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 73649134368     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.07.008     Document Type: Article

References (32)

1. Gawaz M., Langer H., May A.E., Gawaz M., Langer H., and May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 115 (2005) 3378-3384
2. Marquardt L., Ruf A., Mansmann U., et al. Course of platelet activation markers after ischemic stroke. Stroke 33 (2002) 2570-2574
3. Fuster V., Badimon L., Badimon J.J., et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). New Engl J Med 326 (1992) 310-318
4. Vaduganathan M., Alviar C.L., Arikan M.E., et al. Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. Am Heart J 156 (2008) 1002.e1-e7
5. Undas A., Brummel-Ziedins K.E., and Mann K.G. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 109 (2007) 2285-2292
6. Born G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194 (1962) 927-929
7. Ozaki Y., Satoh K., Yatomi Y., et al. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 218 (1994) 284-294
8. Cardinal D.C., and Flower R.J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmcol Meth 3 (1980) 135-158
9. Kaplan K.L., and Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57 (1981) 199-202
10. Ohkawa R., Hirowatari Y., Nakamura K., et al. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. Clin Biochem 38 (2005) 1023-1026
11. Johnston G.I., Kurosky A., McEver R.P., Johnston G.I., Kurosky A., and McEver R.P. Structural and biosynthetic studies of the granule membrane protein, GMP-140, from human platelets and endothelial cells. J Biol Chem 264 (1989) 1816-1823
12. de Bruijne-Admiraal L.G., Modderman P.W., Von dem Borne A.E., and Sonnenberg A. P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 80 (1992) 134-142
13. Shattil S.J., Hoxie J.A., Cunningham M., et al. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 260 (1985) 11107-11114
14. Metzelaar M.J., Wijngaard P.L., Peters P.J., et al. CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 266 (1991) 3239-3245
15. National Committee for Clinical Laboratory Standards. Transport and processing of blood specimens for coagulation. Testing and general performance of coagulation assay, Approved guideline. NCCLS document, 3rd ed (1998), National Committee for Clinical Laboratory Standards, Franklin Lakes, NJ H21-A3, P1-23
16. Polack B., Schved J.F., Boneu B., and Groupe d'Etude sur l'Hemostase et la Thrombose' (GEHT). Preanalytical recommendations of the 'Groupe d'Etude sur l'Hemostase et la Thrombose' (GEHT) for venous blood testing in hemostasis laboratories. Haemostasis 31 (2001) 61-68
17. Ruf A., Pick M., Deutsch V., et al. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Brit J Haematol 98 (1997) 51-56
18. Kieffer N., and Phillips D.R. Platelet membrane glycoproteins: functions in cellular interactions. Annu Rev Cell Biol 6 (1990) 329-357
19. Hu H., Daleskog M., and Li N. Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding. Thromb Res 100 (2000) 161-166
20. Hu H., Forslund M., and Li N. Influence of extracellular calcium on single platelet activation as measured by whole blood flow cytometry. Thromb Res 116 (2005) 241-247
21. Hagberg I.A., and Lyberg T. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Platelets 11 (2000) 137-150
22. Schmidt V., Hilberg T., Franke G., Glaser D., and Gabriel H.H. Paraformaldehyde fixation induces a systematic activation of platelets. Platelets 14 (2003) 287-294
23. Schmitz G., Rothe G., Ruf A., et al. European Working Group on Clinical Cell Analysis. Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemostasis 79 (1998) 885-896
24. Winokur R., and Hartwig J.H. Mechanism of shape change in chilled human platelets. Blood 85 (1995) 1796-1804
25. Reid T.J., LaRussa V.F., Esteban G., et al. Cooling and freezing damage platelet membrane integrity. Cryobiology 38 (1999) 209-224
26. Anderson R.A., Jones C.J.H., and Goodfellow J. Is the fatty meal a trigger for acute coronary syndromes. Atherosclerosis 159 (2001) 9-15
27. Broijersen A., Karpe F., Hamsten A., Goodall A.H., and Hjemdahl P. Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation. Atherosclerosis 137 (1998) 107-113
28. Hübl W., Assadian A., Lax J., et al. Assessing aspirin-induced attenuation of platelet reactivity by flow cytometry. Thromb Res 121 (2007) 135-143
29. Catella-Lawson F. Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects. Neurology 57 (2001) S5-S7
30. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
31. Li N., Hu H., Hjemdahl P., et al. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. Thromb Res 111 (2003) 165-170
32. Cao Y.J., Wang Y.M., Zhang J., Zeng Y.J., and Liu C.F. The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction. Thromb Thrombolysis 27 (2009) 233-238